4Davis KC,Small RE.Budesonide inhalation powder:a review of its pharmacologic properties and role in the treatment of asthma.Pharmacotherapy,1998,18(4):720 -728.
5Rimensberger PC,Burek-Kozlowska A,Morell A,et al.aerosolized immunoglobulin treatent of respiratory syncytial virus infection in infants[J].Pediatr Infect Dis J,2005,15(32):209.
6Bojillot JL,Aubertin JM,Fornes P,et al.Dieulafooys ulcer;Combined endoscopic and laparoscopic treatmeat[J].Endoscopy,1996,28(4):394-395.
5Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma [J]. Allergy, 2006, 61 (5) : 518 - 526.
6Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature [J]. Chest, 2004, 126(1) : 213 -219.
7Akpan A, Morgan R. Oral candidiasis[J].Postgrad Med J, 2002, 78(922) : 455 -459.
8Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid- induced oropharyngeal adverse events: results from a meta-analysis [ J]. Ann Allergy Asthma Immunol, 2007, 98 (3) : 225 - 238.
9Irwin RS, Richardson ND. Side effects with inhaled corticosteroids: the physician's perception[ J]. Chest, 2006, 130( 1 Suppl) : 41S - 53S.
10National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma. Expert panel report 3 : guidelines for the diagnosis and management of asthma[ R/ OL]. Bethesda (MD) : National Heart, Lung, and Blood Institute (US) , 2007. http://www, ncbi. nlm. nih. gov/books/NBK7233/.
